Huadong Medicine Co Ltd. Stock Analysis 000963.SZ

Huadong Medicine Co., Ltd. engages in the production and sale of antibiotics, proprietary Chinese medicine, chemical synthetic medicine, and genetic engineering drugs. The company is headquartered in Hangzhou, Zhejiang and currently employs 18,265 full-time employees. The company went IPO on 2000-01-27. The firm mainly operates its business through four segments. The Manufacturing Business segment is engaged in the research and development, production and marketing of specialized medicines, medicines for chronic diseases, as well as special medicines. The Commercial Business segment is engaged in the sales of medicines, medical devices, and ginseng and antler pieces. The International Medical Aesthetics Business segment is engaged in the production and sales of regeneration products, hyaluronic acids and botulinum toxin products. The firm also operates the Headquarters segment. The firm conducts its business in the domestic and overseas markets.